MethodHub Software Limited announced a strategic partnership with Datafoundry, a leading provider of purpose-built AI/ML SaaS solutions for pharmacovigilance and life sciences. The disclosure was made pursuant to Regulation 30 read with Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

The partnership aims to deliver end-to-end, technology-led Pharmacovigilance (PV) and pharma-tech solutions to global pharmaceutical, biotech, and life sciences enterprises. The collaboration combines MethodHub's capabilities in PV operations, regulatory compliance, and global delivery with Datafoundry's advanced AI-powered solutions.

Key Partnership Details

  • Datafoundry will contribute its AI-powered solutions including Safety AI (end-to-end safety case management with intelligent automation), Signal AI (AI-driven signal detection and risk management), and Literature Monitor (automated global literature surveillance with AI-driven screening)
  • MethodHub will continue to deliver comprehensive Pharmacovigilance services including case processing, adverse event reporting, signal detection, aggregate reporting, audit readiness, and quality assurance
  • The partnership aims to help organizations transition from fragmented, manual PV processes to intelligent, automated, and scalable safety operations

Company Background

MethodHub is a publicly listed global technology services company serving 40+ global clients with a team of 500+ professionals across the USA, India, Canada, and Thailand. The company holds globally recognized certifications including ISO 27001, ISO 9001, SOC 2 Type II, and HIPAA HITECH.

MethodHub also operates QuantumHire, a proprietary AI-powered full-time hiring platform that supports clients in scaling specialized Pharmacovigilance talent efficiently.

Management Commentary

Mr. Ahobilam, CEO and Executive Director of MethodHub Software Limited, stated: "Pharmacovigilance is no longer a back-office compliance function; it is central to patient safety and brand trust in the pharmaceutical industry. Through our partnership with Datafoundry, we are bringing together cutting-edge AI platforms, domain expertise, and scalable service delivery to help clients build future-ready, intelligent PV ecosystems."

The disclosure was signed by Muthukrishnan Shanmuga Thevar, Company Secretary & Compliance Officer (Membership No. A61530) on July 06, 2026.